In-house pharma counsel hiring outside lawyers arrive with a specific regulatory or litigation problem. They search for "Hatch-Waxman litigation attorney Wilmington," "505(b)(2) FDA counsel," or "REMS submission lawyer Washington DC." A single archive page filtered by tag cannot rank for that range of intents, and most lawyer-directory plugins offer a contact form rather than indexable per-attorney URLs with FDA pathway, matter, and credential fields.

SleekRank reads a Google Sheet with one row per attorney, plus columns for FDA pathways handled, matter types, FDA enforcement experience, USPTO registration number, PhD or PharmD flag, ANDA filings handled, billing model, bar admissions, and city. Each row renders through one WordPress base page. A new pathway added is a one-cell edit, and the directory reflects current scope on the next cache refresh.

FDA pathway is the column that earns the click. NDA, ANDA, 505(b)(2), and BLA map to very different regulatory tactics, and a PharmD or chemistry PhD signals an attorney who can read a CMC submission without a translator. With those fields driven by a sheet, a new enforcement matter or a generic challenge flows straight into every page that references the attorney, the pathway hub, and the matter hub.

Pharmaceutical law is a category where in-house counsel arrive knowing both the FDA pathway and the matter shape. A generics general counsel typing "Paragraph IV Hatch-Waxman attorney chemistry PhD" needs that exact combination ranked, not a generic life-sciences directory. Per-attorney and per-pathway pages let each attorney accrue authority for the submissions and litigation they actually run, which is the most common shape of pharma-counsel searches.

Maintaining that corpus by hand collapses the moment a partner shifts from generics to biologics work or a new enforcement matter reshapes their profile. SleekRank turns the firm's intake sheet into the SEO surface, so the business development team updating practice fields is the same team updating the page that ranks for them. In-house pharma teams find the right specialist before the submission deadline matters.